Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A Tutorial

Michael J. Sweeting, Mark J. Rutherford, Dan Jackson, Sangyu Lee, Nicholas R. Latimer, Robert Hettle and Paul C. Lambert
Additional contact information
Michael J. Sweeting: Statistical Innovation, AstraZeneca, Cambridge, UK
Mark J. Rutherford: Department of Population Health Sciences, University of Leicester, UK
Dan Jackson: Statistical Innovation, AstraZeneca, Cambridge, UK
Sangyu Lee: Department of Population Health Sciences, University of Leicester, UK
Nicholas R. Latimer: School of Health and Related Research, University of Sheffield, Sheffield, UK
Robert Hettle: Health Economics and Payer Evidence, AstraZeneca, Cambridge, UK
Paul C. Lambert: Department of Population Health Sciences, University of Leicester, UK

Medical Decision Making, 2023, vol. 43, issue 6, 737-748

Abstract: Background Different parametric survival models can lead to widely discordant extrapolations and decision uncertainty in cost-effectiveness analyses. The use of excess hazard (EH) methods, which incorporate general population mortality data, has the potential to reduce model uncertainty. This review highlights key practical considerations of EH methods for estimating long-term survival. Methods Demonstration of methods used a case study of 686 patients from the German Breast Cancer Study Group, followed for a maximum of 7.3 y and divided into low (1/2) and high (3) grade cancers. Seven standard parametric survival models were fit to each group separately. The same 7 distributions were then used in an EH framework, which incorporated general population mortality rates, and fitted both with and without a cure parameter. Survival extrapolations, restricted mean survival time (RMST), and difference in RMST between high and low grades were compared up to 30 years along with Akaike information criterion goodness-of-fit and cure fraction estimates. The sensitivity of the EH models to lifetable misspecification was investigated. Results In our case study, variability in survival extrapolations was extensive across the standard models, with 30-y RMST ranging from 7.5 to 14.3 y. Incorporation of general population mortality rates using EH cure methods substantially reduced model uncertainty, whereas EH models without cure had less of an effect. Long-term treatment effects approached the null for most models but at varying rates. Lifetable misspecification had minimal effect on RMST differences. Conclusions EH methods may be useful for survival extrapolation, and in cancer, EHs may decrease over time and be easier to extrapolate than all-cause hazards. EH cure models may be helpful when cure is plausible and likely to result in less extrapolation variability. Highlights In health economic modeling, to help anchor long-term survival extrapolation, it has been recommended that survival models incorporate background mortality rates using excess hazard (EH) methods. We present a thorough description of EH methods with and without the assumption of cure and demonstrate user-friendly software to aid researchers wishing to use these methods. EH models are applied to a case study, and we demonstrate that EHs are easier to extrapolate and that the use of the EH cure model, when cure is plausible, can reduce extrapolation variability. EH methods are relatively robust to lifetable misspecification.

Keywords: survival extrapolation; health technology assessment; excess hazard models; modeling; overall survival (search for similar items in EconPapers)
Date: 2023
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X231184247 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:43:y:2023:i:6:p:737-748

DOI: 10.1177/0272989X231184247

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().